Fleury I, Laverdure E. Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-cell Therapy for Indolent Lymphoma. Can Hematol Today [Internet]. 2023 Nov. 6 [cited 2023 Nov. 28];2(3):5-11. Available from: https://canadianhematologytoday.com/article/view/2-3-fleury_laverdure